P53 codon 11, 72, and 248 gene polymorphisms in endometriosis

International Journal of Biological Sciences

Volumn 2, Issue 4, 2006, Pages 188-193

  Hsieh, Yao Yuan ^a,b   Lin, Chich Sheng ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Endometriosis; Gene; p53; Polymorphism; SNP

Indexed keywords

ARGININE; GLUTAMIC ACID; GLUTAMINE; LYSINE; PROLINE; PROTEIN P53; RESTRICTION ENDONUCLEASE; THREONINE;

ALLELE; ARTICLE; CODON; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; ELECTROPHORESIS; ENDOMETRIOSIS; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; GENOTYPE; HEALTH SURVEY; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION;

EID: 33746135241     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.2.188     Document Type: Article

References (50)

1. Bischoff FZ, Simpson JL. Heritability and molecular genetic studies of endometriosis. Hum Reprod Update 2000, 6:37-44.
2. Nakayama K, Toki T, Zhai YL, Lu X, Horiuchi A, Nikaido T, Konishi I, Fujii S . Demonstration of focal p53 expression without genetic alterations in endometriotic lesions. Int J Gynecol Pathol 2001 20:227-31.
3. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ, Campbell IG. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996 56:3534-9.
4. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. Role of a p53 polymorphism in the development of human papilloma virus-associated cancer. Nature 1998 393:229-34.
5. Helland A, Langerod A, Johnsen H, Olsen AO, Skovlund E, Borresen-Dale AL. p53 polymorphism and risk of cervical cancer. Nature 1998 396:530-1.
6. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999 29:697-702.
7. Wang NM, Tsai CH, Yeh KT, Chen SJ, Chang JG. P53 codon 72 arg polymorphism is not a risk factor for carcinogenesis in the Chinese. Int J Mol Med 1999 4:249-52.
8. Bischoff FZ, Heard M, Simpson JL. Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis. J Reprod Immunol 2002 55:49-64.
9. Mhawech P, Kinkel K, Vlastos G, Pelte MF. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study. Int J Gynecol Pathol 2002 21:401-6.
10. Vercellini P, Trecca D, Oldani S, Fracchiolla NS, Neri A, Crosignani PG. Analysis of p53 and ras gene mutations in endometriosis. Gynecol Obstet Invest 1994 38:70-1.
11. Schneider J, Jimenez E, Rodriguez F, del Tanago JG. c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis. Oncol Rep 1998 5:49-52.
12. Horiuchi A, Osada R, Nakayama K, Toki T, Nikaido T, Fujii S. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53. Gynecol Oncol 1998;70:295-9
13. Butz J, Wickstrom E, Edwards J. Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction. BMC Biotechnol 2003 3:11.
14. Goldman MB, Cramer DW. Current concepts in endometriosis. Prog Clin Biol Res 1989 323:17-23.
15. Strathy JH, Molgaard CA, Coulam CB, Melton LJ III. Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril 1982 38:667-72.
16. Treloar SA, O'Connor DT, O'Connor VM, Martin NG. Genetic influences on endometriosis in an Australian twin sample. Fertil Steril 1999 71:701-10.
17. Jiang X, Morland SJ, Hitchocock A, Thomas EJ, Campbell IG. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res 1998 58:1707-12
18. Kosugi Y, Elias S, Malinak LR, Nagata J, Isaka K, Takayama M, Simpson JL, Bischoff FZ. Increased heterogeneity of chromosome 17 aneuploidy in endometriosis. Am J Obstet Gynecol 1999 180:792-7.
19. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997 88:323-31.
20. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Eng J Med 1993 329:1318-27.
21. Loging WT, Reisman D. Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53. Cancer Epidemiol Biomarkers Prev 1999 8:1011-6.
22. Zehbe I, Voglino G, Wilander E, Genta F, Tommasion M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 1999 354:218-9.
23. Kupryjanczyk J, Bell DA, Yandell DW, Scully RE, Thor AD. p53 expression in ovarian borderline tumors and stage I carcinomas. Am J Clin Pathol 1994 102:671-6.
24. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Eng J Med 1994 331:1259-64.
25. Steiner MS, Zhang X, Wang Y, Lu Y. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer Res 2000 60:4419-25.
26. Takeda A, Shimada H, Nakajima K, Suzuki T, Hori S, Hayashi H, Arima M, Kouzu T, Ochiai T, Isono K. Impact of circulating p53 autoantibody monitoring after endoscopic resection in mucosal gastric cancer. Endoscopy 2000 32:740-1.
27. Nutt CL, Noble M, Chambers AF, Cairncross JG. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res 2000 60:4812-8.
28. Miyazaki T, Kato H, Shitara Y, Yoshikawa M, Tajima K, Masuda N, Shouji H, Tsukada K, Nakajima T, Kuwano H. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer 2000 89:955-62.
29. Pich A, Margaria E, Chiusa L. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival. J Clin Oncol 2000 18:2948-56.
30. Boley SE, Anderson EE, French JE, Donehower LA, Walker DB, Recio L. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination. Cancer Res 2000 60:2831-5.
31. Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH, Maruo T. Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population. J Soc Gynecol Investig 2004 11:232-6.
32. Kawamura M, Yamashita T, Segawa K, Kaneuchi M, Shindoh M, Fujinaga K. The 273rd codon mutants of p53 show growth modulation activities not correlated with p53-specific transactivation activity. Oncogene 1996 12:2361-7.
33. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, Caporaso NE, Fraumeni JF Jr, Rice JM. Mutations of the Kras and p53 genes in gastric adenocarcinomas from a highincidence region around Florence, Italy. Cancer Res 1995 55:2665-72.
34. Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wei Q. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep 2004 11:1115-20.
35. Shen H, Liu Z, Strom SS, Spitz MR, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Duvic M, Ananthaswamy HN, Wei Q. p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol 2003 121:1510-4.
36. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003 18:377-85.
37. Papadakis ED, Soulitzis N, Spandidos DA. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer 2002 87:1013-8.
38. Langerod A, Bukholm IR, Bregard A, Lonning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Borresen-Dale AL. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Cancer Epidemiol Biomarkers Prev 2002 11:1684-8.
39. Lin SR, Lee YJ, Tsai JH. Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab 1994 78:483-91.
40. Niu Y, Yan Y, Ji J, Luo B. A study of p53 gene mutations in squamous cell carcinoma in eyes. Zhonghua Yan Ke Za Zhi 1999 35:219-22
41. Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, Hewer A, Phillips DH, Ryberg D, Haugen A, Harris CC. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res 2001 61:6350-5.
42. Manahan KJ, Taylor DD, Gercel-Taylor C. Clonal heterogeneity of p53 mutations in ovarian cancer. Int J Oncol 2001 19:387-94.
43. Wang JY, Lin SR, Hsieh JS, Hsu CH, Huang YS, Huang TJ. Mutations of p53 gene in gastric carcinoma in Taiwan. Anticancer Res 2001 21:513-20.
44. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000 60:3333-7.
45. Zhou M, Gu L, Yeager AM, Findley HW. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. Leukemia 1998 12:1756-63.
46. Wu MT, Chen MC, Wu DC. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett 2004 205:61-8.
47. Koushik A, Platt RW, Franco EL. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 2004 13:11-22.
48. Pillai MR, Sreevidya S, Pollock BH, Jayaprakash PG, Herman B. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India. J Cancer Res Clin Oncol 2002 128:627-31
49. Inserra P, Abrahamsen M, Papenfuss M, Giuliano AR. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk. Int J STD AIDS 2003 14:800-4.
50. Manfredi S, Masetti S, Botto N, Colombo MG, Terrazzi M, Vassalle C, Biagini A, Andreassi MG. P53 codon 72 polymorphism in coronary artery disease: no evidence for association with increased risk or micronucleus frequency. Environ Mol Mutagen 2002 40:110-5.